FGF18

Across TCGA pan-cancer cohorts, FGF18 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated FGF18 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher FGF18 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FGF18 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUSC and UCEC are the cancer types where FGF18 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	III,IV	0.147	0.664	.028	12	view →
UCEC	DFS	Median	II,III,IV	1.000	0.444	.042	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

FGF18–LUSC (OS)

Open the LUSC breakdown →